Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Foundation to attend the ESCMID Global 2025

Emily Gauruhn, Researcher at the Access to Medicine Foundation, will attend the ESCMID Global 2025 Congress, where she will share insights on the Foundation’s work related to antimicrobial resistance (AMR).

Date

14 April 2025

Location

Vienna, Austria

The Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025) event brings together leading experts in infectious diseases and clinical microbiology to exchange ideas and explore the latest innovations. The event features five days of keynote lectures, oral sessions, workshops, symposia, and poster presentations. 

Representing the Access to Medicine Foundation, researcher Emily Gauruhn will speak at a session on April 14, 2025. Emily will share insights from the Foundation's latest research on AMR, including a publication on antimicrobial research and development. The report underscores the vital role of stewardship and access planning in ensuring innovative antibiotics and antifungals reach patients worldwide fighting drug-resistant infections. She will engage with fellow attendees and share insights on the pharmaceutical sector’s accountability in addressing AMR.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Explore our research reports and publications
News

New methodology paves the way for the Foundation's 2026 AMR Benchmark

28 January 2025
News

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

23 May 2024

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved